SPOTLIGHT -
Never Means Never: International March of the Living Honors the Medical Community
This year, the March of the Living honors of Holocaust victims and survivors, the medical community, and Dr Anthony Fauci.
Dementia-Related Psychosis Treatment Receives Complete Response Letter
CRL cites lack of substantial evidence of efficacy needed for approval.
Pediatric ADHD Medication Gets FDA Green Light
This once-daily sprinkleable capsule may help patients aged 6 to 17 years with attention-deficit/hyperactivity disorder.
FDA Warning: Bipolar Medication May Increase Risk for Arrhythmias
Is this treatment for bipolar disorder risking patients’ heart health?
Biden Administration Plan Tackles Drug Addiction Crisis
Government funding for the drug addiction crisis is on the way.
Patients With Tardive Dyskinesia Feel Unheard, Social Media Listens
The first study to gather unsolicited patient responses via social media finds 3 negative themes.
Rx Dog Therapy: How Man’s Best Friend Helps Veterans With PTSD
Service animals can help save veterans’ lives.
Insomnia Treatment Without Daytime Sleepiness
This investigational dual orexin receptor antagonist improved sleep overnight and daytime functioning.
FDA Says: No Approval, No Label, No Service
As patients flock to CBD as a “natural alternative” to medications, the FDA continues to crack down on false claims.
Tweet Gone Too Far? Goldwater Rule Violation
An ex-Yale psychiatrist who skirted the Goldwater Rule is suing the university over her termination.
Difficulties Diagnosing Geriatric Bipolar Disorder
Misdiagnosis and late diagnosis may be preventing older patients with bipolar disorder from getting proper care.
New Data for Alzheimer Agent Presented at International Conference
This monoclonal antibody showed significant slowing of decline in patients with Alzheimer disease.
A Potential Benzodiazepine Replacement
This social anxiety disorder treatment does not directly activate gamma-amino butyric acid (GABA-A) receptors, setting it apart from benzodiazepines.
Organized Psychiatry and Medicine Condemn Anti-Asian Violence
It’s time for psychiatry to take the high road in addressing racism, especially as the psychological toll becomes more evident.
Incoming Data: News from Naturalistic MDD Clinical Trial
New data from the ongoing SHORELINE study may bring good news for treating MDD.
Supporting the World’s Aging Population
The International Psychogeriatric Association shares opportunities to improve worldwide geriatric care.
LGBTQ+ Through the Ages: Stonewall’s Impact
What socio-cultural events impacted the older LGBTQ+ generations, and how do they inform their current mental health status?
Clinician, Patients Take the Fight for Psilocybin To Court
Should a patient at the end of her life have access to psilocybin, even if it’s illegal?
Journal Publication Brings Good News for Novel Schizophrenia Treatment
The chief medical officer of Karuna shares his thoughts exclusively with Psychiatric Times.
ADHD Treatment Gets the Green Light
The FDA has approved the New Drug Application for a once-daily ADHD treatment.
Sleepiness Treatment Under FDA Review
If approved, this formulation of sodium oxybate will be the first once-nightly oxybate treatment for daytime sleepiness.
Can COVID-19 Enter the Brain?
A new study considers how the virus might enter the brain and cause cognitive issues.
The First of Its Kind: A New Bipolar Depression Treatment
If approved by the FDA, this treatment would be the first therapy for treating depressive episodes in both bipolar I and II disorder in 2 different forms.
Hitting the Fast Track: Alcohol Use Disorder Treatment Filing with FDA
An alcohol use disorder treatment has 4 potential advantages over existing treatments.
7 Black Physicians That Made History In the Mental Health Field
What black physicians have influenced the mental health field, changing it for good?
Alzheimer Disease Vaccine: Less Talk, More Numbers
A study on a new Alzheimer disease vaccine lacks concrete numbers.
The Interconnected Mind and Heart
The American Heart Association released a statement recognizing the importance of the relationship between mental well-being and cardiovascular disease.
The Myth of Blue Monday
Is the purported “saddest day of the year” evidence-based?
Dropping the X-Waiver for Buprenorphine
The Department of Health and Human Services moves to reduce administrative procedural barriers to OUD treatment.
Gene Pathway Linked to Development of Schizophrenia
Researchers have discovered a gene signaling pathway associated with a higher risk for developing schizophrenia.